CN1133446C - Gufukang liniment for treating bone disease - Google Patents
Gufukang liniment for treating bone disease Download PDFInfo
- Publication number
- CN1133446C CN1133446C CNB011084650A CN01108465A CN1133446C CN 1133446 C CN1133446 C CN 1133446C CN B011084650 A CNB011084650 A CN B011084650A CN 01108465 A CN01108465 A CN 01108465A CN 1133446 C CN1133446 C CN 1133446C
- Authority
- CN
- China
- Prior art keywords
- radix
- liniment
- gufukang
- radix aconiti
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940040145 liniment Drugs 0.000 title claims abstract description 24
- 239000000865 liniment Substances 0.000 title claims abstract description 24
- 208000020084 Bone disease Diseases 0.000 title claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 10
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 239000002699 waste material Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 17
- 206010005963 Bone formation increased Diseases 0.000 abstract description 7
- 206010011732 Cyst Diseases 0.000 abstract description 3
- 208000031513 cyst Diseases 0.000 abstract description 3
- 231100000915 pathological change Toxicity 0.000 abstract description 2
- 230000036285 pathological change Effects 0.000 abstract description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001369615 Aristolochia fangchi Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000746716 Typhonium Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 235000015096 spirit Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 206010061363 Skeletal injury Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 2
- 241000283956 Manis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to gufukang liniment which belongs to an external medicine for treating bone diseases. The present invention uses giant typhonium rhizome, aristolochia fangchi, raw wild aconite, raw sichuan axonite root, dried ginger, lightyellow sophora root, manchurian wildginger, olibanum, myrrh and safflower as raw materials, and the raw materials are lixiviated by spirits to prepare the gufukang liniment. The present invention is suitable for treating pathological changes of hyperosteogeny, which result from various reasons, and simultaneously, the present invention has unique efficacy for thecal cyst, and has good therapeutic effect on accumulated pain. The present invention has the advantages of simple and convenient preparation, low cost, no uncomfortableness for long-time inunction on the diseased region of people, and no side effect.
Description
The present invention relates to a kind of medicine for the treatment of the orthopaedics illness, particularly a kind of is the external used medicine that raw material is made with the vegetable Chinese herbal medicine.
Orthopaedics diseases such as hyperosteogeny, arthritis, scapulohumeral periarthritis bring great misery for many people, particularly middle-aged and elderly people.Though there is the Chinese medicine and western medicine of many oral administration and externallies all to can be used to slow down the pain of bone injury illness, can strengthen the muscle and bone, effect a radical cure the bone disease, eliminate ailing Chinese medicine externally applied liniment, still rare.In the prior art, it is open that the Chinese invention patent that a publication number is arranged is CN1217197A applies on May 26th, 1999, it is a kind of liniment for treating bony spur, be with Radix Angelicae Sinensis, Flos Carthami, Squama Manis, Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Et Radix Notopterygii, Sanguis Draxonis, Rhizoma Chuanxiong, Herba Pyrolae, Olibanum, Herba Asari, Agkistrodon, Radix Saposhnikoviae, the Radix Angelicae Dahuricae, the north meson, Rhizoma Zingiberis Recens, Nidus Vespae, Radix Clematidis, NANXIANG, Pericarpium Zanthoxyli, Magnetitum, Mei Bing, Camphora totally 23 flavor Chinese herbal medicine is raw material, dry through the process of preparing Chinese medicine respectively, after grinding powder, soak with the sealing of 95% ethanol by a certain percentage again, form according to the tincture extracting method extraction of routine.This liniment for treating bony spur has expelling pathogenic wind and eliminating dampness, blood circulation promoting and blood stasis dispelling, mass dissipating and swelling eliminating, dredge the meridian passage, the effect of promoting the circulation of QI analgesic.But its raw material prescription has adopted too many fragrance to walk string and has searched the wind medicine, and life-time service has the fraud of impairment of YIN consumption misfortune, can cause having palpitation, cardiopalmus, insomnia, symptom such as fidgety; Also make raw material in the prescription, should not produce in batches and promote with the national two classes Squama Manis that watches for animals; With the liniment that ethanol is made as extractant, often use makes skin allergy easily, is unfavorable for the treatment of bone injury; The treatment of bone injury illness needs the long course of treatment, but owing to the defective of this liniment on prescription, makes the narrow application range of its set a broken bone illness, and also inaccessible ideal cure rate more can't be treated the plyability orthopaedic disease; In addition, the material medicine that it need be used is too many, and it is cumbersome that manufacture method also seems, manufacturing cost is higher.
The objective of the invention is at above-mentioned the deficiencies in the prior art, choosing common vegetable Chinese herbal medicine is raw material, make extractant and short-cut method is made a kind of Gufukang liniment for treating bone disease with common white spirit, make it can not only extensively treat various bone injury illness effectively, and the cure rate height.
Realize purpose of the present invention by the following technical solutions.
A kind of Gufukang liniment for treating bone disease is characterized in that:
1) its used raw material and weight portion proportioning are Rhizoma Typhonii 8-25, Radix Stephaniae Tetrandrae 5-12, Radix Aconiti Kusnezoffii 6-15. Radix Aconiti 6-15, Rhizoma Zingiberis 3-12, Radix Sophorae Flavescentis 3-10, Herba Asari 3-10, Olibanum 2-8, Myrrha 2-8, Flos Carthami 2-8;
2) its preparation method is, weight portion proportional quantity by raw material takes by weighing each raw material components respectively, wherein Rhizoma Typhonii, Radix Stephaniae Tetrandrae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Zingiberis and Radix Sophorae Flavescentis are pulverized, again each raw material components is mixed, Chinese liquor with at least 60 degree is cooked extractant, presses weight portion proportioning=1 of raw mix and Chinese liquor: 2-3, soaks 5-7 days in hermetic container, filter the waste extracting juice at last, make liniment.
Gufukang liniment for treating bone disease of the present invention, raw materials used preferred weight part ratio range is: Rhizoma Typhonii 12-25, Radix Stephaniae Tetrandrae 5-10, Radix Aconiti Kusnezoffii 6-12, Radix Aconiti 6-12, Rhizoma Zingiberis 3-10, Radix Sophorae Flavescentis 3-8, Herba Asari 3-8, Olibanum 3-6, Myrrha 3-6, Flos Carthami 3-6.
Gufukang liniment for treating bone disease of the present invention, raw materials used optimum weight part proportioning is: Rhizoma Typhonii 14, Radix Stephaniae Tetrandrae 5, Radix Aconiti Kusnezoffii 6.5, Radix Aconiti 6.5, Rhizoma Zingiberis 3, Radix Sophorae Flavescentis 3, Herba Asari 3.5, Olibanum 3.5, Myrrha 3.5, Flos Carthami 3.5.
In the raw material prescription of Gufukang liniment for treating bone disease of the present invention, the property of Rhizoma Typhonii tool dampness, the Radix Stephaniae Tetrandrae detumescence that can dehumidify, Radix Aconiti Kusnezoffii, the Radix Aconiti expelling wind and cold, Olibanum, the Myrrha blood activating and promoting tissue regeneration, Flos Carthami collateral dredging blood stasis dispelling, the Rhizoma Zingiberis warming spleen and stomach for dispelling cold, Radix Sophorae Flavescentis energy antipyretic and itching-stopping, Herba Asari fragrance is walked string, and their compatibilities are proper, the fraud that both can suppress the impairment of YIN consumption misfortune of dry property medicine, can make each drug component Synergistic again, make by the property of the warm-dryness syndrome of medicine in treatment that diseased region is scorching heats, promote and recover local blood circulation, relend the fragrance that helps appropriate amount of drug and walk the power of string, promote the circulation of body inner blood, thereby it is whole to reach conditioning, cures partial purpose.
Gufukang liniment for treating bone disease of the present invention is directly embrocated at diseased region with hands, exerts oneself a little at affected area when applying medicinal lotion or ointment, and with scratch mark degree of being not, wiping to lesions position has burning sensation to be advisable, and repeatedly medicament is imposed on the affected part again after dried slightly to embrocate; Medication every day once, each administration time was advisable with about 20 minutes, each dosage is decided on the diseased region size.
Liniment of the present invention compared with prior art, applied widely, for a variety of causes hyperosteogeny pathological changes extremely, osteoporosis for example, bone lip sample changes, lumbar vertebra hyperosteogeny, intervertebral disk hernia, hyperosteogenys etc. all have significant curative effect, are that other similar medicine is beyond one's reach to the cure rate of thecal cyst; To depositing the property pain of injury of a specified duration, also has good efficacy simultaneously.Following table is the clinical effectiveness statistical data of various bone injury illness.
Gufukang liniment for treating bone disease clinical effectiveness statistical table
| Case | The treatment number | Effective number | The healing number | Effective percentage % | Cure rate % |
| Hyperosteogeny of cervical vertebra | 28 | 26 | 24 | 92.85 | 85.7 |
| Lumbar vertebra hyperosteogeny | 39 | 36 | 35 | 92.3 | 89.7 |
| Intervertebral disk hernia | 25 | 23 | 20 | 92.0 | 80.0 |
| Thecal cyst | 23 | 23 | 23 | 100 | 100 |
| Deposit the property pain of injury of a specified duration | 15 | 13 | 10 | 86.7 | 66.7 |
| Add up to | 130 | 121 | 112 | 93 | 86.1 |
Liniment of the present invention is compared with prior art only done ingenious compatibility with the common Chinese herbal medicine of 10 flavors, and is done property of medicine carrier with Chinese liquor, and simple for production, and cost is low, and no sense of discomfort is embrocated at the human lesion position for a long time, does not have the effect of paying, and welcome by the patient.
Embodiment
Take by weighing 16 kilograms of Rhizoma Typhoniis, 6 kilograms of Radixs Stephaniae Tetrandrae, 7 kilograms of Radix Aconiti Kusnezoffii, 7 kilograms of Radix Aconiti, 4 kilograms of Rhizoma Zingiberiss, 4 kilograms of Radix Sophorae Flavescentiss, 4 kilograms of Herba Asaris, 4 kilograms of Olibanums, 4 kilograms of Myrrhas, 4.5 kilograms on Flos Carthami respectively; Wherein Rhizoma Typhonii, Radix Stephaniae Tetrandrae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Zingiberis and Radix Sophorae Flavescentis are pulverized; Again each material component is mixed,, in hermetic container, soaked 7 days, filter the waste extracting juice at last, make a kind of Gufukang liniment for treating bone disease with 150 kilograms of 63 degree Chinese liquor.
Claims (3)
1. Gufukang liniment for treating bone disease is characterized in that:
1) its used raw material and weight portion proportioning are Rhizoma Typhonii 8-25, Radix Stephaniae Tetrandrae 5-12, Radix Aconiti Kusnezoffii 6-15, Radix Aconiti 6-15, Rhizoma Zingiberis 3-12, Radix Sophorae Flavescentis 3-10, Herba Asari 3-10, Olibanum 2-8, Myrrha 2-8, Flos Carthami 2-8;
2) its preparation method is, weight portion proportional quantity by raw material takes by weighing each raw material components respectively, wherein Rhizoma Typhonii, Radix Stephaniae Tetrandrae, Radix Aconiti Kusnezoffii, Radix Aconiti, Rhizoma Zingiberis and Radix Sophorae Flavescentis are pulverized, again each raw material components is mixed, Chinese liquor with at least 60 degree is cooked extractant, presses weight portion proportioning=1 of raw mix and Chinese liquor: 2-3, soaks 5-7 days in hermetic container, filter the waste extracting juice at last, make liniment.
2. according to the described Gufukang liniment for treating bone disease of claim 1, it is characterized in that said parts by weight of raw materials ratio range is: Rhizoma Typhonii 12-25, Radix Stephaniae Tetrandrae 5-10, Radix Aconiti Kusnezoffii 6-12, Radix Aconiti 6-12, Rhizoma Zingiberis 3-10, Radix Sophorae Flavescentis 3-8, Herba Asari 3-8, Olibanum 3-6, Myrrha 3-6, Flos Carthami 3-6.
3. according to the described Gufukang liniment for treating bone disease of claim 1, it is characterized in that said parts by weight of raw materials proportioning preferably: Rhizoma Typhonii 14, Radix Stephaniae Tetrandrae 5, Radix Aconiti Kusnezoffii 6.5, Radix Aconiti 6.5, Rhizoma Zingiberis 3, Radix Sophorae Flavescentis 3, Herba Asari 3.5, Olibanum 3.5, Myrrha 3.5, Flos Carthami 3.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011084650A CN1133446C (en) | 2001-05-24 | 2001-05-24 | Gufukang liniment for treating bone disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011084650A CN1133446C (en) | 2001-05-24 | 2001-05-24 | Gufukang liniment for treating bone disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1323614A CN1323614A (en) | 2001-11-28 |
| CN1133446C true CN1133446C (en) | 2004-01-07 |
Family
ID=4657282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011084650A Expired - Fee Related CN1133446C (en) | 2001-05-24 | 2001-05-24 | Gufukang liniment for treating bone disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1133446C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083630A (en) * | 2012-11-11 | 2013-05-08 | 李传深 | Plaster for treating osteoproliferation |
| CN104353049A (en) * | 2014-11-25 | 2015-02-18 | 孙颖 | External traditional Chinese medicine for treating idiopathic arthralgia syndrome |
| CN104622986A (en) * | 2015-01-19 | 2015-05-20 | 余金标 | Externally applied traditional Chinese medicine for treating arthritis |
-
2001
- 2001-05-24 CN CNB011084650A patent/CN1133446C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1323614A (en) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN100493594C (en) | Plaster for treating cholecystitis, cholangitis and bile gastritis | |
| CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
| CN1133446C (en) | Gufukang liniment for treating bone disease | |
| CN107007714A (en) | It is a kind of that there is the exterior-applied medical wine for promoting poroma nucleus formation | |
| CN103735763B (en) | One kind treats osteoproliferation and the arthritic Chinese medicine composition of wind-cold and preparation method thereof | |
| CN109700856A (en) | A kind of Chinese medicine external prescription relieved pain with promoting blood circulation and removing obstruction in channels, relaxing muscles and tendons | |
| CN1073861C (en) | External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof | |
| CN1054765C (en) | External-use medicine bag for curing chronic gastritis and its prodn process | |
| CN1485063A (en) | Chinese traditional medicine formulation for rheumatism and its orthopaedic disease | |
| CN106236847A (en) | A kind of Chinese medicine composition treating cervical spondylosis and preparation method thereof and using method | |
| CN112546131A (en) | Preparation and application methods of external-use human black plaster | |
| CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
| CN1157144A (en) | Traditional Chinese medicine prescription for curing soft tissue injury | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN104523959B (en) | A kind of health care massage zaocys dhumnades olein | |
| CN1304764A (en) | Plant night cream for treating pustular acne | |
| CN1115162C (en) | Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof | |
| CN106177785A (en) | A kind of medicine treating cervical spondylosis | |
| CN105560537A (en) | A kind of pharmaceutical composition for treating osteoarthropathy and preparation method thereof | |
| CN104587394A (en) | Traditional Chinese medicine composition for treating delayed union and nonunion | |
| CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
| CN101502598B (en) | Medicament for treating protrusion of lumber vertebral disc and method for preparing the same | |
| CN115554351A (en) | Ointment for treating intervertebral disc protrusion and preparation method thereof | |
| CN117018142A (en) | Bone injury ointment and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |